Company intelligence / Profile preview

Access Industries

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

Access Industries is a global private holding and investment firm founded by Len Blavatnik in 1986. Through its dedicated life sciences arm—Access Biotechnology—it invests in innovative biopharma companies developing transformative therapies for high unmet medical needs across multiple modalities and therapeutic areas. It has backed both private and public biotech firms at all stages of development.

Industry: Investors

Beyond the preview

Go deeper on Access Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Access Industries.

Explore the full profile